Lucintel's latest market report analyzed that western blotting provides attractive opportunities in academic & research institutes, biopharmaceutical & biotechnology companies, and hospitals & diagnostic laboratories. The western blotting market is expected to reach $1.26 billion by 2028 with a CAGR of 5.9%. In this market, consumables is the largest segment by product, whereas academic & research institutes is largest by end use.
Download Brochure of this report by clicking on https://www.lucintel.com/western-blotting-market.aspx
Based on product, the western blotting market is segmented into consumables and instruments. The consumables segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to increasing penetration in research and diagnosis activity.
Browse in-depth TOC on “Western Blotting Market”
100 – Figures/Tables
150 – Pages
The Western Blotting Market is marked by the presence of several big and small players. Some of the prominent players offering western blotting include Bio-Rad, Thermo Fisher, Danaher, Bio-Techne, and Merck.
Request Sample Report:
https://www.lucintel.com/western-blotting-market.aspx
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.